
1. nat immunol. 2011 dec 11;13(2):188-95. doi: 10.1038/ni.2180.

therapeutic blockade pd-l1 lag-3 rapidly clears established blood-stage
plasmodium infection.

butler ns(1), moebius j, pewe ll, traore b, doumbo ok, tygrett lt, waldschmidt
tj, crompton pd, harty jt.

author information: 
(1)department microbiology, university iowa, iowa city, iowa, usa.

comment in
    nat immunol. 2012 feb;13(2):113-5.

infection erythrocytes plasmodium species induces clinical malaria.
parasite-specific cd4(+) cells correlate lower parasite burdens and
severity human malaria needed control blood-stage infection in
mice. however, characteristics cd4(+) cells determine protection or
parasite persistence remain unknown. show infection humans with
plasmodium falciparum resulted higher expression inhibitory receptor
pd-1 associated cell dysfunction. vivo blockade pd-1 ligand
pd-l1 inhibitory receptor lag-3 restored cd4(+) cell function,
amplified number follicular helper cells germinal-center b cells and
plasmablasts, enhanced protective antibodies rapidly cleared blood-stage
malaria mice. thus, chronic malaria drives specific cell dysfunction, and
proper function restored inhibitory therapies enhance parasite
control.

doi: 10.1038/ni.2180 
pmcid: pmc3262959
pmid: 22157630  [indexed medline]

